There’s a new game in town for D2C health business models

There’s a new game in town for D2C health business models

And it’s rapidly evolving in real time!

Why the Hinge Health IPO is so important for digital health

A few thoughts...

Is health-tech entering its ‘influencer’ era?

And what are the pros and cons?

4 questions on President Trump and IVF

I caught up with Conceivable Life Sciences’ Joshua Abram to understand the political landscape and its impact on reproductive health

Care delivery in all 50 states? No longer as common as it used to be

Some digital health companies are getting more targeted with their approach

Latest Posts

Why the Hinge Health IPO is so important for digital health

Why the Hinge Health IPO is so important for digital health

A few thoughts...

Christina Farr
Christina Farr
Is health-tech entering its ‘influencer’ era?

Is health-tech entering its ‘influencer’ era?

And what are the pros and cons?

Christina Farr
Christina Farr
4 questions on President Trump and IVF

4 questions on President Trump and IVF

I caught up with Conceivable Life Sciences’ Joshua Abram to understand the political landscape and its impact on reproductive health

Christina Farr
Christina Farr

From the vault

Why the Hinge Health IPO is so important for digital health

Why the Hinge Health IPO is so important for digital health

A few thoughts...

Christina Farr
Christina Farr
Is health-tech entering its ‘influencer’ era?

Is health-tech entering its ‘influencer’ era?

And what are the pros and cons?

Christina Farr
Christina Farr
4 questions on President Trump and IVF

4 questions on President Trump and IVF

I caught up with Conceivable Life Sciences’ Joshua Abram to understand the political landscape and its impact on reproductive health

Christina Farr
Christina Farr
Care delivery in all 50 states? No longer as common as it used to be

Care delivery in all 50 states? No longer as common as it used to be

Some digital health companies are getting more targeted with their approach

Christina Farr
Christina Farr
The massive opportunity in women's longevity

The massive opportunity in women's longevity

State of the union, and where we go from here

Leslie Schrock
Leslie Schrock
There’s a new game in town for D2C health business models

There’s a new game in town for D2C health business models

And it’s rapidly evolving in real time!

Christina Farr
Christina Farr
How are employers going to pay for cell and gene therapies?

How are employers going to pay for cell and gene therapies?

Let’s get real about the alliance between U.S. health care and employment

Christina Farr
Christina Farr
Why is healthcare so bad at cybersecurity?

Why is healthcare so bad at cybersecurity?

Plus, some thoughts about Transcarent buying Accolade!

Christina Farr
Christina Farr
The formula for a productive investor update email

The formula for a productive investor update email

Because so many of you asked for it!

Christina Farr
Christina Farr
Some tips for raising money in 2025

Some tips for raising money in 2025

Things have gotten a little better in digital health VC land, but it’s still challenging out there!

Leslie Schrock
Christina Farr
Leslie Schrock, +1
A letter to my kids about last week

A letter to my kids about last week

How I’ve been thinking about recent events

Christina Farr
Christina Farr
There’s about to be a lot of AI capital incineration

There’s about to be a lot of AI capital incineration

Health care VCs are flocking to AI - and it’s all starting to feel a lot like crypto

Christina Farr
Christina Farr
FirstBack
12345678
Next Last
Authors